University of Kentucky — Lexington, Kentucky

Public research footprint of University of Kentucky, compiled from the ClinicalTrials.gov public registry.

2,170

Registered studies

599

Active

289

Recruiting now

1,226

Completed

286

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Recurrent Malignant Solid Neoplasm · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Locally Recurrent Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05142696 — A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With… (Active Not Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Kentucky?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.